成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 142253-55-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 142253-55-2
Chemical Structure| 142253-55-2
Structure of 142253-55-2 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 142253-55-2 ]

Related Doc. of [ 142253-55-2 ]

Alternatived Products of [ 142253-55-2 ]
Product Citations

Product Details of [ 142253-55-2 ]

CAS No. :142253-55-2 MDL No. :MFCD01860897
Formula : C9H15NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :NCADHSLPNSTDMJ-UHFFFAOYSA-N
M.W : 201.22 Pubchem ID :2755981
Synonyms :
Chemical Name :N-Boc-Azetidine-3-carboxylic acid

Calculated chemistry of [ 142253-55-2 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.78
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 53.56
TPSA : 66.84 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.23 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.91
Log Po/w (XLOGP3) : 0.42
Log Po/w (WLOGP) : 0.56
Log Po/w (MLOGP) : 0.43
Log Po/w (SILICOS-IT) : -0.06
Consensus Log Po/w : 0.65

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.09
Solubility : 16.4 mg/ml ; 0.0816 mol/l
Class : Very soluble
Log S (Ali) : -1.39
Solubility : 8.18 mg/ml ; 0.0407 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.1
Solubility : 162.0 mg/ml ; 0.804 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.12

Safety of [ 142253-55-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 142253-55-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 142253-55-2 ]
  • Downstream synthetic route of [ 142253-55-2 ]

[ 142253-55-2 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 142253-55-2 ]
  • [ 486415-29-6 ]
YieldReaction ConditionsOperation in experiment
81%
Stage #1: With triethylamine; isobutyl chloroformate In tetrahydrofuran at -20 - -10℃; for 0.25 h;
Stage #2: With ammonium hydroxide In tetrahydrofuran at -20 - 20℃; for 1 h;
1-[(tert-butoxy)carbonyl]azetidine-3-carboxylic acid (4.96 g, 24.65 mmol) and TEA (5.84 ml, 42.0 mmol) were dissolved in THF (60 ml) and cooled to -20°C. Isobutyl chloroformate (4.8 ml, 37.0 mmol) was added slowly and the reaction mixture stirred at ^10°C for 15 min. 28percent aqueous ammonia (7.46 ml, 394 mmol) was added and the mixture allowed to warm to room temperature and stirred for 1 h. The reaction mixture was quenched with sat. NaHC<(aq) and extracted with DCM (3 x 100 ml). The combined organic extracts were dried (Na2S04), filtered and evaporated in vacuo. Purification by flash chromatography using a gradient elution of 20-100percent EtOAc / heptane followed by 1-4percent MeOH / EtOAc afforded the title compound (3.99 g, 81 percent) as a white solid. 1 H-NMR (CDCI3, 250 MHz): d[ppm]= 5.47 (s, 2H), 4.22 - 4.01 (m, 4H), 3.34 - 3.15 (m, 1 H), 1 .46 (s, 9H) HPLCMS (Method A): [m/z]: 222.95 [M+Na]+
63% With ammonium acetate; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; To a solution of 1-(tert-butoxycarbonyl)azetidine-3-carboxylic acid (from Activate Scientific. 0.25 g, 1.2 mmol), ammonium acetate (0.14 g, 1.9 mmol) and N,N,N′,N′-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate (0.71 g, 1.9 mmol) in N,N-dimethylformamide (4 mL) was added N,N-diisopropylethylamine (0.43 mL, 2.5 mmol). The mixture was stirred at room temperature overnight. The mixture was diluted with MeOH and purified on prep-LCMS (XBridge C18 column, eluting with a gradient of acetonitrile/water containing 0.1percent ammonium hydroxide, at flow rate of 60 mL/min) to give the desired product (0.156 g, 63percent). LCMS calculated for C9H16N2O3Na (M+Na)+: m/z=223.1. Found: 223.0
Reference: [1] Patent: WO2017/68089, 2017, A2, . Location in patent: Page/Page column 234; 235
[2] Patent: US2014/121198, 2014, A1, . Location in patent: Paragraph 0688; 0689
[3] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 5, p. 757 - 761
[4] Patent: WO2010/60952, 2010, A1, . Location in patent: Page/Page column 81
[5] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 10, p. 3037 - 3040
  • 2
  • [ 142253-55-2 ]
  • [ 870089-49-9 ]
Reference: [1] Patent: WO2014/173289, 2014, A1,
[2] Patent: TWI602818, 2017, B,
[3] Patent: WO2018/137573, 2018, A1,
[4] Patent: US2015/361067, 2015, A1,
[5] Patent: US2008/58348, 2008, A1,
[6] Patent: WO2011/61214, 2011, A1,
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 142253-55-2 ]

Amides

Chemical Structure| 887591-62-0

[ 887591-62-0 ]

1-(tert-Butoxycarbonyl)-3-methylazetidine-3-carboxylic acid

Similarity: 1.00

Chemical Structure| 610791-05-4

[ 610791-05-4 ]

Methyl 1-Boc-azetidine-3-carboxylate

Similarity: 0.96

Chemical Structure| 1346674-10-9

[ 1346674-10-9 ]

1-tert-Butyl 3-ethyl azetidine-1,3-dicarboxylate

Similarity: 0.94

Chemical Structure| 177947-96-5

[ 177947-96-5 ]

tert-Butyl 3-formylazetidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 142253-56-3

[ 142253-56-3 ]

1-Boc-Azetidine-3-yl-methanol

Similarity: 0.88

Carboxylic Acids

Chemical Structure| 887591-62-0

[ 887591-62-0 ]

1-(tert-Butoxycarbonyl)-3-methylazetidine-3-carboxylic acid

Similarity: 1.00

Chemical Structure| 534602-47-6

[ 534602-47-6 ]

1-(tert-Butoxycarbonyl)-3-methylpiperidine-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 88495-54-9

[ 88495-54-9 ]

(S)-1-(tert-Butoxycarbonyl)piperidine-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 183062-96-6

[ 183062-96-6 ]

2-(1-(tert-Butoxycarbonyl)azetidin-3-yl)acetic acid

Similarity: 0.83

Chemical Structure| 1221818-81-0

[ 1221818-81-0 ]

7-(tert-Butoxycarbonyl)-7-azabicyclo[2.2.1]heptane-2-carboxylic acid

Similarity: 0.81

Related Parent Nucleus of
[ 142253-55-2 ]

Aliphatic Heterocycles

Chemical Structure| 610791-05-4

[ 610791-05-4 ]

Methyl 1-Boc-azetidine-3-carboxylate

Similarity: 0.96

Chemical Structure| 1346674-10-9

[ 1346674-10-9 ]

1-tert-Butyl 3-ethyl azetidine-1,3-dicarboxylate

Similarity: 0.94

Chemical Structure| 177947-96-5

[ 177947-96-5 ]

tert-Butyl 3-formylazetidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 142253-56-3

[ 142253-56-3 ]

1-Boc-Azetidine-3-yl-methanol

Similarity: 0.88

Chemical Structure| 486415-29-6

[ 486415-29-6 ]

tert-Butyl 3-carbamoylazetidine-1-carboxylate

Similarity: 0.87

Azetidines

Chemical Structure| 887591-62-0

[ 887591-62-0 ]

1-(tert-Butoxycarbonyl)-3-methylazetidine-3-carboxylic acid

Similarity: 1.00

Chemical Structure| 610791-05-4

[ 610791-05-4 ]

Methyl 1-Boc-azetidine-3-carboxylate

Similarity: 0.96

Chemical Structure| 1346674-10-9

[ 1346674-10-9 ]

1-tert-Butyl 3-ethyl azetidine-1,3-dicarboxylate

Similarity: 0.94

Chemical Structure| 177947-96-5

[ 177947-96-5 ]

tert-Butyl 3-formylazetidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 142253-56-3

[ 142253-56-3 ]

1-Boc-Azetidine-3-yl-methanol

Similarity: 0.88

; ;